Daewoong releases Novosis, an innovative medical device

Published: 2013-03-15 06:56:00

Updated: 2013-03-15 06:56:00

Daewoong Pharmaceutical said Tuesday it has launched Novosis, a new-concept medical device combining bone graft and rhBMP-2 (recombinant human bone morphogenetic protein-2).

Novosis is produced from recombinant E. coli. which harboring cDNA of human BMP-2 through genetic engineering. The high ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK